SCHEMBL5709784

SCHEMBL5709784

CCN(CC)Cc1ccc(OC(=O)c2cn(CC)c3c(OC(F)(F)F)c(F)c(F)cc3c2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 6/20 0.35
KDM4E B2RXH2 6/20 0.35
HPGD P15428 5/20 0.35
HSD17B10 Q99714 5/20 0.35
TSHR P16473 2/20 0.35
STAT3 P40763 1/20 0.35
PMP22 Q01453 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
KMT2A Q03164 2/20 0.34
ATM Q13315 1/20 0.34
RAB9A P51151 1/20 0.34
PIM1 P11309 1/20 0.33
TOP1 P11387 3/20 0.33
PIK3CD O00329 1/20 0.33
PIK3R1 P27986 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CG P48736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5710090 0.92 LSS (0.38) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5709767 0.91 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5709750 0.85 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5528122 0.81 STAT3 (0.47) ALDH1A1KDM4EHPGDHSD17B10STAT3
SCHEMBL5709797 0.77 MEN1 (0.40) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5709783 0.75 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5529702 0.75 STAT3 (0.45) ALDH1A1KDM4EHPGDHSD17B10STAT3
SCHEMBL5526211 0.73 STAT3 (0.47) ALDH1A1KDM4EHPGDHSD17B10STAT3
SCHEMBL3869129 0.71 TOP1 (0.45) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL5535429 0.71 STAT3 (0.49) ALDH1A1KDM4EHPGDHSD17B10STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732897-A1 QUINOLONE CARBOXYLIC ACID DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE CONDITIONS Bayer Pharmaceuticals Corporation (US) 2006-12-20 EP disclosed
WO-2005097752-A1 QUINOLONE CARBOXYLIC ACID DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE CONDITIONS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-20 WO disclosed